Linical Co

Linical Co OCF Growth YoY

The Year-over-Year Operating Cash Flow Growth of Linical Co (2183.T) as of Nov 7, 2026 is -351.51 %. In the previous year, Year-over-Year Operating Cash Flow Growth was -45.36 % — a change of 674.91% (lower).

OCF Growth YoY

-351.51 %

YoY

674.91%

Last updated:

Year-over-Year Operating Cash Flow Growth of Linical Co is 2026 -351.51 % . Year-over-Year Operating Cash Flow Growth of Linical Co was 2025 -45.36 % . It decreases by 674.91% lower compared to the previous year.

The Linical Co OCF Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Growth YoY
Date
OCF Growth YoY
Jan 1, 2019
-158.21 JPY
Jan 1, 2020
250.61 JPY
Jan 1, 2021
-98.02 JPY
Jan 1, 2022
6,811.45 JPY
Jan 1, 2023
12.74 JPY
Jan 1, 2024
-39.80 JPY
Jan 1, 2025
-45.36 JPY
Jan 1, 2026
-351.51 JPY
The Linical Co OCF Growth YoY history
YEAROCF Growth YoYYoY
-351.51 %+674.91%
-45.36 %+13.97%
-39.80 %-412.50%
12.74 %-99.81%
6,811.45 %-7,049.05%
-98.02 %-139.11%
250.61 %-258.41%
-158.21 %+289.19%
-40.65 %-255.66%
26.11 %-84.01%
163.35 %-7.65%
176.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

Year-over-Year Operating Cash Flow Growth of Linical Co is -351.51 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Operating Cash Flow Growth Linical Co since 2006 – with annual values, charts, and detailed analysis.

OCF growth measures the percentage change in operating cash flow. Growing OCF indicates improving cash generation from core operations.

To evaluate Year-over-Year Operating Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Operating Cash Flow Growth.

Year-over-Year Operating Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Operating Cash Flow Growth's Linical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Linical Co

All Key Metrics — Linical Co